Ivana Mikulandra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ivana Mikulandra has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Iva Habinovec
Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, HR-10000 Zagreb, Croatia
2 shared publications - Predrag Novak
Department of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, HR-10000 Zagreb, Croatia
2 shared publications - Tomislav Jednačak
University of Zagreb, Faculty of Science, Department of Chemistry
2 shared publications - Hana Čipčić Paljetak
Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Šalata 3, HR-10000 Zagreb, Croatia
1 shared publication - Ivan Grgičević
Labtim Adria d.o.o., Jaruščica 7A, HR-10020 Zagreb, Croatia
1 shared publication - Jelena Parlov Vuković
NMR Centre, Ruđer Bošković Institute, Bijenička cesta 54, 10000 Zagreb, Croatia
1 shared publication
Latest Publications
- Open Access
- 14 January 2026
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14, 3139
Anti-infective macrozones: design, biological evaluation and structure-activity relationships
Background and purpose: To discover novel compounds active against sensitive and resistant bacterial strains, a series of novel azithromycin-thiosemicarbazone conjugates, the macrozones, have been synthesized and their biological activity evaluated with corresponding (quantitative) structure-activity relationship ((Q)SAR) analyses conducted. Experimental approach: A systematic variation of thiosemicarbazone side-chains and coupling at positions 4''-, 3-, and 9a of the azithromycin scaffold has resulted in a novel class of bacterial ribosome inhibitors. Key results: Compared to azithromycin, the activity of 4''-macrozones has shown the greatest improvements against efflux-resistant S. pneumoniae and S. aureus, as well as very good activity of 4'' derivatives against E. faecalis. QSAR calculations indicate that the antibacterial activity of macrozones is primarily determined by the position of the thiosemicarbazone side chain. Among the conjugated derivatives, the 4''-substituted macrozones exhibit the highest overall activity against a range of sensitive and efflux-resistant Gram-positive bacteria, as well as against Gram-negative E. coli strains, while those substituted at 9a- and 3- positions are found to be less potent. The antibacterial activity of macrozones is favourably influenced by larger fractions of their cationic and zwitterionic forms, their capacity for hydrogen bond formation, and the extension of p-electron delocalization involving the thiosemicarbazone moiety. Conclusion: The results obtained provide a sound basis for guiding further medicinal chemistry efforts toward the discovery of more potent macrolide anti-infectives, with particular emphasis on resistant bacteria that pose a serious threat to human health.
- 14 January 2026
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14, 3139
Open AccessAnti-infective macrozones: design, biological evaluation and structure-activity relationships
Background and purpose: To discover novel compounds active against sensitive and resistant bacterial strains, a series of novel azithromycin-thiosemicarbazone conjugates, the macrozones, have been synthesized and their biological activity evaluated with corresponding (quantitative) structure-activity relationship ((Q)SAR) analyses conducted. Experimental approach: A systematic variation of thiosemicarbazone side-chains and coupling at positions 4''-, 3-, and 9a of the azithromycin scaffold has resulted in a novel class of bacterial ribosome inhibitors. Key results: Compared to azithromycin, the activity of 4''-macrozones has shown the greatest improvements against efflux-resistant S. pneumoniae and S. aureus, as well as very good activity of 4'' derivatives against E. faecalis. QSAR calculations indicate that the antibacterial activity of macrozones is primarily determined by the position of the thiosemicarbazone side chain. Among the conjugated derivatives, the 4''-substituted macrozones exhibit the highest overall activity against a range of sensitive and efflux-resistant Gram-positive bacteria, as well as against Gram-negative E. coli strains, while those substituted at 9a- and 3- positions are found to be less potent. The antibacterial activity of macrozones is favourably influenced by larger fractions of their cationic and zwitterionic forms, their capacity for hydrogen bond formation, and the extension of p-electron delocalization involving the thiosemicarbazone moiety. Conclusion: The results obtained provide a sound basis for guiding further medicinal chemistry efforts toward the discovery of more potent macrolide anti-infectives, with particular emphasis on resistant bacteria that pose a serious threat to human health.
- 1 January 2026
- Published by Croatian Chemical Society in Croatica Chemica Acta
- Vol. 99 (2)
Macrolide Structure, Bioactivity and Interactions: a Review
- 1 January 2026
- Published by Croatian Chemical Society in Croatica Chemica Acta
- Vol. 99 (2)
Macrolide Structure, Bioactivity and Interactions: a Review